{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-24-000053","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.820589+00:00","generated_at":"2026-05-30T00:54:53.495077+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intensity Therapeutics Q3 net loss $3.5M; first patient dosed in Phase 2 TNBC study","bullets":["Net loss of $3.5M for Q3 2024 vs $2.3M a year ago; R&D expenses rose to $2.2M.","Cash and equivalents $2.8M as of Sept 30, 2024; expected to fund operations into Q1 2025.","First patient dosed in Phase 2 INVINCIBLE-4 study of INT230-6 in presurgical triple-negative breast cancer.","Phase 3 INVINCIBLE-3 sarcoma study received regulatory authorizations in 8 countries; enrollment target 333 patients.","Regulatory approvals obtained from Health Canada, EMA, Swissmedic, and Australia's TGA during Q3 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-24-000053","json":"https://secwatch.observer/filing/0001567264-24-000053.json","markdown":"https://secwatch.observer/filing/0001567264-24-000053.md","text":"https://secwatch.observer/filing/0001567264-24-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000053/0001567264-24-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000053/intensity-20241113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:54:53.495077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}